Cardiopulmonary Bypass Withdrawn Phase 3 Trials for Nesiritide (DB04899)

Also known as: Cardiopulmonary bypass / Bypass, Cardiopulmonary

IndicationStatusPhase
DBCOND0032101 (Cardiopulmonary Bypass)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00530361An Efficacy and Safety Study for Nesiritide in Heart Failure Patients With Reduced Kidney Function Undergoing Coronary Artery Bypass Graft Surgery Requiring Cardiopulmonary Bypass (CPB Pump or Heart Lung Machine)Treatment